Umbilical cord blood transplant with pooled stem cell product shows 96% survival and no GVHD in leukemia patients

A new way of using umbilical cord blood for treating blood diseases could make the treatment more accessible to patients who need a stem cell transplant. A Phase II clinical trial of patients ...
MPR

Adding Dilanubicel to Single-Unit Cord-Blood Transplantation Has Favorable Safety Profile

Patients treated with dilanubicel demonstrated faster hematopoietic recovery and had a markedly lower incidence of severe acute GVHD. HealthDay News — Adding dilanubicel, a cryopreserved, cord blood ...
MedPage Today on MSN

Pooled Cord Blood Transplants Achieve Near-Perfect Results in Early Trial

Disease-free survival of 96% with no severe GVHD in acute leukemia, other blood cancers ...

Pooled Umbilical Cord Blood Boosts Stem Cell Transplant Success, Trial Finds

By Dennis Thompson HealthDay ReporterWEDNESDAY, April 29, 2026 (HealthDay News) — A new way of using umbilical cord blood — ...
RFID Journal

Automating Processes to Ensure Right Blood, Right Patient, Right Time Every Time

Transfusion medicine is the branch of medicine dealing with the removal and/or transfusion of blood or blood components, including aspects related to hemovigilance. Transfusions between donors and ...